Author Claim Review

 Quick Explanation Copied

 Long Explanation

Career impact: With 509-529 papers, ~34,600 citations and an h-index of ~100 (OpenAlex: h=100; Semantic Scholar-listed: h=99), Bikle ranks among the most-cited living vitamin D researchers. His annual citation counts rose from ~1,100/yr (2012-2017) to ~2,000/yr (2020-2025), showing sustained, growing influence rather than a legacy-only profile.

Signature science: Bikle's most influential first-author works are broad synthesis reviews (e.g., Vitamin D Metabolism, Mechanism of Action, and Clinical Applications, ~1,933 citations; Nonclassic Actions of Vitamin D, ~975) Major vitamin D metabolism review and mechanistic discoveries: the free-hormone fraction of 25(OH)D (~624 citations) Free 25(OH)D fraction paper, human 1α-hydroxylase cloning CYP27B1 cloning paper, and vitamin D-dependent antimicrobial peptide induction after injury Vitamin D innate immunity in wounds. His own mouse work is mechanistically rigorous: keratinocyte-specific VDR deletion delayed wound closure (297 ± 81% vs 390 ± 47% closure, p < 0.02) with downregulated Tgfb1, Shh, Gli1, Bmp4, and Lef1, and data deposited publicly (GSE68727) VDR knockout wound healing data. Small n (≥3/genotype) and single genetic background are real limitations the authors themselves note.

Guideline authority and self-correction: Bikle co-authored the Endocrine Society's nonskeletal-effects scientific statement Endocrine Society nonskeletal vitamin D statement and the 2024 vitamin D prevention guideline 2024 Endocrine Society vitamin D guideline. Notably, his own 2016 review acknowledged that randomized trials often fail to confirm preclinical extraskeletal benefits Extraskeletal vitamin D review with RCT gap — evidence of intellectual honesty against pro-vitamin-D hype. Some earlier viewpoint pieces (e.g., evolutionary vitamin D arguments) present interpretation without empirical data Evolutionary viewpoint on vitamin D, the weakest strand in an otherwise exceptionally strong portfolio. No declared conflicts of interest were recorded in the supplied extractions. Confidence: high on metrics and mechanistic contributions; moderate on inferences about independence from industry influence, which the supplied data cannot fully address.

 BGPT Author Review

Scientific Quality

Near world-class: h-index ~99-100 with ~34,600 citations across 509-529 papers over six decades, spanning mechanistic mouse genetics (VDR/CaSR knockouts), human genetics (CYP27B1 cloning), assay methodology (free 25(OH)D), and guideline authorship. Deductions for small-n animal studies (≥3 mice/group), reliance on single genetic backgrounds, and some speculative viewpoint essays lacking empirical support.

Communication Quality

His reviews (Endocrine Reviews, JCEM) are heavily cited and structurally clear, and he candidly flags the preclinical-RCT gap — unusually honest. Some viewpoint pieces are interpretive without data, slightly blurring evidence tiers for readers.

Author Novelty

He created or co-created several fields: epidermal vitamin D metabolism, VDR as skin tumor suppressor, VDR-crosstalk with β-catenin and Hedgehog, and the free 25(OH)D debate. Later work (lncRNAs in VDR signaling, Med1 lineage switching) shows continued frontier movement, though many outputs are consolidation reviews.

Scientific Rigor

Uses conditional knockouts, public data deposition (GSE68727), and quantified outcomes with p-values; acknowledges limitations and biases explicitly. Weaknesses: small mouse cohorts, genetic-background confounding not fully addressed, and occasional non-empirical viewpoint claims presented alongside data-driven work.